English | Español

Abbott Laboratories
Patient Daily Report | May 22, 2023

Dr. Lakkireddy: 'Assert-IQ ICM is a significant advancement amongst the tools that are currently available for diagnoses of irregular heart rhythms'
Press release submission | Oct 26, 2018

ABBOTT: Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

Press release submission | Oct 18, 2018

ABBOTT: New Study Shows Abbott's Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care
Marian Johns | Nov 17, 2017

Abbott receives approval in Japan for device to treat mitral regurgitation heart disease
Carol Ostrow | Nov 3, 2017

XIENCE implants show benefits in cardiac recovery
Mark Iandolo | Oct 26, 2017

Abbott rolls out new DRG Neurostimulator System to help combat chronic pain
Kathy Adams | Oct 6, 2017

Abbott completes acquisition of Alere
Carol Ostrow | Oct 3, 2017

Freestyle Libre gains FDA approval, ending need to prick finger for glucose testing, Abbott says

Trending
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'